Skip to content

Avicanna Expands its Epilepsy Research Program with a New Collaboration with the University of Toronto

15 September 2022

Avicanna Reports Q2 2022 Financial Statement

16 August 2022

Avicanna and Ei. Ventures Enter into an Agreement to Develop and Commercialize Adaptogen Nutraceuticals

20 July 2022

RE+PLAY ANNOUNCES THE NBPA AS AN OFFICIAL PARTNER

12 July 2022

Avicanna Completes its First Commercial Export of its Derma-Cosmetics Brand Pura H&W™ into the European Union

7 July 2022

Avicanna Sells Stake in Majority-Owned Colombian Subsidiary Sativa Nativa

24 June 2022
« Prev1234567Next »